Gurugram-based dialysis healthcare provider VitusCare has raised US$3 million in a Series B funding round, as it looks to expand its network of dialysis centres, develop AI-powered healthcare delivery solutions and strengthen its workforce.
The fundraise follows a period of rapid growth in which the company nearly tripled its revenue and reported positive corporate EBITDA in FY26.
The round attracted Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, along with several angel investors.
VitusCare has expanded its network from 22 dialysis centres in late 2024 to more than 60 across nine states and over 50 cities. During the same period, its workforce grew from 110 to 300 employees.
The company said it has treated more than 35,000 patients and delivered over 8 lakh dialysis sessions.
The company attributed its positive corporate EBITDA in FY26 to faster breakeven at newly opened centres and same-centre growth of more than 30%.
VitusCare Targets 100 Centres by FY27
Unlike standalone dialysis chains that establish their own facilities, VitusCare operates through a capital-light ‘shop-in-shop’ model, setting up specialised dialysis units within existing hospitals.
The model allows it to expand its geographical reach by using existing healthcare infrastructure.
With the latest funding, VitusCare plans to take its network beyond 100 centres by the end of FY27. It is also exploring expansion opportunities in select Asian markets.
A portion of the capital will go towards developing AI-native business modules for healthcare delivery. The company also plans to establish a Technician Academy to address the need for trained dialysis professionals as its operations scale.
Prabhat Shrivastava, Founder and CEO of VitusCare, said, “This fundraise marks an important milestone in VitusCare’s journey. We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency.
The confidence our investors have shown in us reinforces our approach to disciplined growth, improving centre-level performance and strengthening our operational foundation.
As we expand our network, we remain focused on maintaining consistent care standards while making quality dialysis services more accessible across underserved markets.”
Vasavi Vittal, Founder and Managing Director of Liberty Ridge Capital, said, “VitusCare’s capital-light model offers a differentiated approach to delivering specialised dialysis care through existing hospital infrastructure. Its growth in network reach, revenue and centre-level performance demonstrates the strength of its operating model.
We see an opportunity for VitusCare to build on this foundation and expand its presence across India and select international markets.”
VitusCare Medlife Pvt Ltd provides dialysis and related services, including regular haemodialysis, continuous renal replacement therapy (CRRT), sustained low-efficiency dialysis (SLED), plasmapheresis, blood transfusion and access-creation support.
The Gurugram-based company focuses on expanding access to specialised kidney care in underserved markets.

